STOCK TITAN

XOMA (XOMA) CEO granted 126,813 performance units and new RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hughes Owen reported acquisition or exercise transactions in this Form 4 filing.

XOMA Royalty Corp director and Chief Executive Officer Owen Hughes reported new equity awards. On March 16, 2026, he received 126,813 Performance Stock Units, each representing a contingent right to one share of common stock, which vest only if the stock reaches specified price targets and he remains in service.

He was also granted 82,428 restricted stock units payable solely in common stock. These RSUs vest in four equal 25% installments on each of the first four anniversaries of March 11, 2026, subject to continued service. Following these awards, he holds 180,696 common shares directly, 295 common shares indirectly via a 401(k) plan, and 102,000 depositary shares of 8.375% Series B cumulative stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hughes Owen

(Last) (First) (Middle)
C/O XOMA ROYALTY CORPORATION
2200 POWELL STREET, SUITE 310

(Street)
EMERYVILLE CA 94608

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
XOMA Royalty Corp [ XOMA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/16/2026 A 82,428(1) A $0 180,696 D
Common Stock 295 I By 401(k) Plan
Depositary Shares - 8.375% Series B Cumulative Stock 102,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Stock Units (2) 03/16/2026 A 126,813 (2) (2) Common Stock 126,813 $0 126,813 D
Explanation of Responses:
1. Represents a grant of restricted stock units payable solely in common stock that will vest as to 25% on each of the first four anniversaries of March 11, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date.
2. Each performance stock unit ("PSU") represents a contingent right to receive one share of common stock. The PSUs vest upon the common stock achieving a specified price per share, subject to the Reporting Person's continued service to the Issuer through each vesting date.
Remarks:
/s/ Maricel Montano, Attorney-in-Fact for Owen Hughes 03/17/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did XOMA (XOMA) CEO Owen Hughes receive?

Owen Hughes received 126,813 Performance Stock Units and 82,428 restricted stock units. Both awards are granted at no cash cost and are payable in common stock, subject to future vesting conditions tied to service and, for PSUs, stock price targets.

How do the new XOMA (XOMA) restricted stock units vest for the CEO?

The 82,428 restricted stock units vest in four equal 25% installments on each of the first four anniversaries of March 11, 2026. Vesting requires Owen Hughes to continue serving the company through each applicable vesting date.

What are the vesting conditions for XOMA (XOMA) CEO performance stock units?

Each of the 126,813 performance stock units converts into one common share only if XOMA’s stock achieves specified price levels. Vesting also depends on Owen Hughes’ continued service to the company through the applicable vesting dates.

How many XOMA (XOMA) common shares does the CEO hold after these grants?

After the reported awards, Owen Hughes holds 180,696 common shares directly and 295 common shares indirectly through a 401(k) plan. These holdings reflect his position following the March 16, 2026 equity grants disclosed in the Form 4.

What other XOMA (XOMA) securities does the CEO own besides common stock?

In addition to common shares and equity awards, Owen Hughes holds 102,000 depositary shares of XOMA’s 8.375% Series B cumulative stock. These depositary shares represent a separate security class from common stock as reported in the Form 4 holdings section.

Does the XOMA (XOMA) Form 4 show any stock sales by the CEO?

The filing reports only grant or award acquisitions of performance stock units and restricted stock units, with no open-market stock sales. The transactions are compensation-related equity awards rather than purchases or disposals of existing XOMA common shares.
XOMA Royalty Corporation

NASDAQ:XOMA

View XOMA Stock Overview

XOMA Rankings

XOMA Latest News

XOMA Latest SEC Filings

XOMA Stock Data

316.35M
12.16M
Biotechnology
Pharmaceutical Preparations
Link
United States
EMERYVILLE